background preloader

Winter Wallpaper from the Fox Foundation

Winter Wallpaper from the Fox Foundation
One-Time Monthly In Tribute Team Fox Tweet HOME › Our Role & Impact › FoxFeed Blog The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you. National Institutes of Health Receives $3 Billion Spending Boost March 22, 2018 The spending deal was released last night and the bill must be passed by this Friday, March 23. New $6 Million Program Looks at Causes of Parkinson's The Michael J. Ask the MD: Parkinson's Diagnosis and Biomarkers In the latest "Ask the MD" video, Dr. Senator Cory Booker (D-NJ) Tells PD Advocates: 'What You Do Matters' March 21, 2018 Senator Booker gave a keynote speech to nearly 300 advocates in Washington, D.C. for the 2018 Parkinson's Policy Forum. Collaboration Most Ambitious Initiative toward a Cure March 20, 2018 The Lancet Neurology calls the AMP PD program the "most ambitious initiative so far to find a cure for Parkinson's." Pharma Company Buys Up MJFF-funded Biotech and Motor Symptom Therapy March 19, 2018 March 14, 2018 Dr.

Awkward Stock Photos Cleveland Clinic Joins 23andme In The Search For Genetic Clues To Parkinson’s Disease February 14, 2012 In an effort to study the interactions between genomics and Parkinson’s disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson’s patients to participate in research by contributing their DNA to a research database and completing online surveys about their health. Currently, little is known about how genes relate to Parkinson’s disease, the effectiveness of treatments, or the natural course of the disease. The goal of this collaborative research effort – which also has support from the Michael J. “We are aware of the limitations of today’s treatments, so we are always thinking about what we can do to advance the care of this incurable disease,” said Andre Machado, MD, PhD, Director of Cleveland Clinic’s Center for Neurological Restoration. “The quality of the research will depend heavily on sample size. 23andMe first assembled its Parkinson’s disease research initiative in June 2009. About 23andMe

Metformin can substantially reduce the risk of Parkinson's disease in diabetes, study suggests A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than 2-fold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57%. This study also found that by including metformin in the therapy, no increased risk in developing Parkinson's disease was recorded. Metformin, found in the French lilac, "Galega officinalis," was originally used in traditional European medicine, and introduced into France and Britain in the 1950s for the treatment of diabetes. Professor Mark Wahlqvist, lead author of the study commented, "An exciting aspect of the finding is that metformin seems to be working to protect the brain against neurodegeneration which contributes to Parkinsonismin. It appears that metformin has opened new ways to look at major diseases of modern society and how we may reduce the growing burdens of such diseases.

'Brain pacemaker' effective for years against Parkinson's disease A "brain pacemaker" called deep brain stimulation (DBS) remains an effective treatment for Parkinson's disease for at least three years, according to a study in the June 2010 online issue of Neurology®, the medical journal of the American Academy of Neurology. But while improvements in motor function remained stable, there were gradual declines in health-related quality of life and cognitive abilities. First author of the study is Frances M. DBS is a treatment for Parkinson's patients who no longer benefit from medication, or who experience unacceptable side effects. In the DBS procedure, a neurosurgeon drills a dime-size hole in the skull and inserts an electrode about 4 inches into the brain. Researchers evaluated 89 patients who were stimulated in a part of the brain called the globus pallidus interna and 70 patients who were stimulated in a different part of the brain called the subthalamic nucleus.

13 Most Awkward Stock Photos Most people only see stock images that have actually been purchased to illustrate some kind of idea or feeling, but the people who make stock images work to ensure there is an image out there for just about any conceivable notion. As a result, there are a lot of seriously strange stock photos with no apparent use other than humoring people, check out some of the funniest images collected at this hilarious blog called Awkward Stock Photos ( Via Neatorama ). There's nothing like a relaxing, almost orgasmic experience than spending your evening with a cactus, if I do say so myself. She's either having too much fun with her cosmetic surgery, or she's a funky mummy. This is quite different from the gifts my dog leaves for me. I bet this is not a Kamasutra position. Sweet dreams. Stock women models are really crazy. Frontpage of the most successful "dating for seniors" website. Totally random arm hanging from the rafters, WTF? Found thanks to Jill Harness' post at Neatorama.

Tai chi could benefit Parkinson’s disease patients By Dr Ananya Mandal, MD A new study found that a six-month program of Tai Chi exercises helped people with various stages of Parkinson's disease improve stability, their ability to walk and reduced the frequency of falls. The study, published this week in the compared a six-month tailored Tai Chi program to resistance training and stretching to see which was most effective at improving functional movement, walking and balance for Parkinson's patients. Parkinson's is a neurological disorder caused by a loss of neurons that produce dopamine , a chemical involved with muscle function and movement coordination. For the study the researchers randomly assigned 195 men and women ages 40 to 85 who were in stages one to four of Parkinson's disease (on a scale of one to five) to the exercise groups. At the end of the study the Tai Chi group did better than the stretching group on a few measures: leaning without losing balance, having better directional control of their body, and walking skills.

Freezing Parkinson's in its Tracks Freezing Parkinson's in its TracksWednesday, May 2, 2012 TAU researcher developing therapy to halt symptoms in Parkinson's patients Parkinson's disease, a disorder which affects movement and cognition, affects over a million Americans, including actor Michael J. Fox, who first brought it to the attention of many TV-watching Americans. It's characterized by a gradual loss of neurons that produce dopamine. Mutations in the gene known as DJ-1 lead to accelerated loss of dopaminergic neurons and result in the onset of Parkinson's symptoms at a young age. The ability to modify the activity of DJ-1 could change the progress of the disease, says Dr. Based on a short protein derived from DJ-1 itself, the peptide has been shown to freeze neurodegeneration in its tracks, reducing problems with mobility and leading to greater protection of neurons and higher dopamine levels in the brain. Guarding dopamine levels As we age, we naturally lose dopamine-producing neurons. Filling an urgent need

Sleep Improves Functioning in Parkinson’s Patients, but Reasons Remain Elusive Sleep Improves Functioning in Parkinson’s Patients, but Reasons Remain Elusive New Study Published in the Journal of Parkinson's Disease June 20, 2012 Some Parkinson’s patients report that their motor function is better upon awakening in the morning, which is contrary to what would be expected after a night without medication. This phenomenon, known as sleep benefit, has been studied but no consistent variables have been found and in the last decade there has been little new research. A new study, published in the June issue of the Journal of Parkinson’s Disease, assesses a large sample of Parkinson’s disease (PD) patients and confirms that some patients experience sleep benefit, both overnight and following afternoon naps, but finds no significant variables between those who do benefit and those who do not. The study included 243 PD patients who completed a comprehensive screening questionnaire covering the range of motor and non-motor symptoms occurring in PD. Dr. Dr.

theCHIVE

Related: